uniQure
Employee Participants6
Total Rating68
Revenue$0
Developer of human gene-based therapies. The company has developed a platform to bring new disease-modifying therapies to patients with severe disorders. The company's pipeline includes gene-based therapies for lipoprotein lipase deficiency, or LPLD, Sanfilippo B, Parkinson's Disease and Hemophilia B. Read More
Headquarters P.O. Box 22506, Amsterdam, 1100 DA, NLD
Website www.uniqure.com
75/100